Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Fakhry

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Journal of Voice : Official Journal of the Voice Foundation|July 1, 2020
Features of Mild-to-Moderate COVID-19 Patients With DysphoniaJerome R Lechien, Carlos M Chiesa-Estomba, Pierre Cabaraux, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 29, 2026
Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical TrialChristophe Le Tourneau, Xavier Liem, France Nguyen, et al.
Bulletin Du Cancer|February 9, 2024
[National standard for the treatment of squamous cell carcinoma of upper aerodigestive tract]Gilles Dolivet, Béatrix Barry, Cyril Abdeddaim, et al.
Bulletin Du Cancer|February 28, 2024
[French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment]Béatrix Barry, Gilles Dolivet, Florian Clatot, et al.
Cell Reports. Medicine|October 19, 2022
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variantOlivier Demaria, Laurent Gauthier, Marie Vetizou, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Journal of Voice : Official Journal of the Voice Foundation|July 1, 2020
Features of Mild-to-Moderate COVID-19 Patients With DysphoniaJerome R Lechien, Carlos M Chiesa-Estomba, Pierre Cabaraux, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 29, 2026
Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical TrialChristophe Le Tourneau, Xavier Liem, France Nguyen, et al.
Bulletin Du Cancer|February 9, 2024
[National standard for the treatment of squamous cell carcinoma of upper aerodigestive tract]Gilles Dolivet, Béatrix Barry, Cyril Abdeddaim, et al.
Bulletin Du Cancer|February 28, 2024
[French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment]Béatrix Barry, Gilles Dolivet, Florian Clatot, et al.
Cell Reports. Medicine|October 19, 2022
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variantOlivier Demaria, Laurent Gauthier, Marie Vetizou, et al.
Pageof 14